SavedAdd your journal

Journals / Marmara Medical Journal / 2001 / Cilt: 14 - Sayı: 4

INTRODUCTION TO CLINICAL PRACTICE: AN IMPORTANT CONTRIBUTION OF GENERAL MEDICINE TO MEDICAL EDUCATION

Çağrı KALACA
Ahmet ARZIK
Sibel KALACA
Pemra ÜNALAN
Pages
255–258
Publication Date
2016-12-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the etiology there are mutation deficits in some genes and resultant mutational changes in amyloid precursor protein, presenilin 1 and 2, apolipoprotein E and low-density- lipoprotein-bound receptor protein (1).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alzheimer’s Disease (AD) is a progressive disease involving the loss of several cognitive functions.
📊
Key Findings & Data:Alzheimer’s Disease (AD) is a progressive disease involving the loss of several cognitive functions.
💡
Conclusion & Impact:In the etiology there are mutation deficits in some genes and resultant mutational changes in amyloid precursor protein, presenilin 1 and 2, apolipoprotein E and low-density- lipoprotein-bound receptor protein (1).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Alzheimer’s Disease (AD) is a progressive disease involving the loss of several cognitive functions. In the etiology there are mutation deficits in some genes and resultant mutational changes in amyloid precursor protein, presenilin 1 and 2, apolipoprotein E and low-density- lipoprotein-bound receptor protein (1).

🔖

Cite This Article

KALACA, Ç., ARZIK, A., KALACA, S., ÜNALAN, P. (2016). INTRODUCTION TO CLINICAL PRACTICE: AN IMPORTANT CONTRIBUTION OF GENERAL MEDICINE TO MEDICAL EDUCATION. Marmara Medical Journal, Cilt: 14 - Sayı: 4, 255–258. https://ajindex.com/articles/688697

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Victor M, Ropper AH. Degenerative diseases of the nervous system. In: Adam's and Victor's Principles of neurology. 7th ed. USA: McGrawHill, 2001:1114-1116.
  2. Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer's disease. Drugs 2001:61;41-52.
  3. Kaplan H, Sadock B. Dementia. In: Kaplan and Sadock's Synopsis of Psychiatry. Middle East ed., 8th ed. Giza - Egypt: Wiliams & Wilkins, ¡998:328-345. World Health Organization. The ICD-IO Classification of Mental and Behavioural Disorders. World Health Organization, Genova, 1992, Delirium, dementia, and amnestic and other cognitive disorders. In: The Task Force on DSM-IV and other committees and work groups of manual of mental disorders: DSM- IV. 4th ed. American Psychiatric Association, Washington, DC, 1994:123-163.
  4. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the ITinCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, neurology 1984:34; 939-944.
  5. Kumral E, Acarer A. Alzheimer hastalığında tanı kriterleri ve genel klinik özellikler. İn: Alzheimer Hastalığı, Kutay FZ, ed. İzmir: Ege University Press, 2000:1-18. Çağrı Yalgın, et al Zurad EG. new treatments of Alzheimer disease: a review. Drug Benefit Trends 2001: 13:27-40.
  6. Terry RD, Masliah E, Hansen LA. Structural basis of the cognitive alteration in Alzheimer's disease. In: Terry RD, Ratzman R, Bick RL, eds. Alzheimer Disease. Raven Press, Hew York, 1994:179-196. Ratzman R. Alzheimer's disease, n Eng J Pled 1986:363:964-973. Rozemuiier JM. neuropathology of dementias. Syllabus 2001, The Amsterdam International Medical Summer School, "Bridging neurology 8c Psychiatry: Dementia, Depression, Schizophrenia and Addiction". July 15-28, 2001, Amsterdam, the netherlands. Sezer C, Mem iş L. Alzheimer hastalığı histopatolojisi. Demans Dergisi 2001:1:42-49. Rutay FZ. Alzheimer hastalığının etyopatogenezindeki biyokimyasal mekanizmalar. In: Alzheimer Hastalığı, Rutay FZ, ed. İzmir: Ege University Press, 2000:19- 51. Lewis J, Dickson DW, Lin WL et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001:293:1487-1491.
  7. Götz J, Chen F, van Dorpe J, Tiitsch RM. Formation of neurofibrillay tangles in P301L tau transgenic mice induced by Ap42 fibrils. Science 2001 -.293; 1491-1495.
  8. McGieenon BM, Dynan RB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer's disease. Br J Clin Pharmacol 1999:48:471- 480. Ben